There are provided novel compounds of formula (I) wherein R.sup.1,
R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, M, T, U, Y, V an W
am as defined in die specification and pharmaceutically acceptable salts
thereof; together with processes for their preparation, compositions
containing them and their use in therapy. The compounds are inhibitors of
nitric oxide synthase and are thereby particularly useful in the
treatment or prophylaxis of inflammatory disease and pain. 1